Positron Emission Tomography - Computed Tomography (PET-CT) Scan as a Diagnostic Method in Unknown Primary Tumors
NCT00269373 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 136
Last updated 2012-02-22
Summary
Is PET-CT scan better than PET or CT alone in diagnosing primary tumours in patients with unknown primary tumors? Can information obtained with PET-CT replace other clinical and radiological investigations? Is PET/CT cost-effective?
Conditions
- Unknown Primary Tumor
Interventions
- PROCEDURE
-
PET-CT
no drugs included
Sponsors & Collaborators
-
Rigshospitalet, Denmark
lead OTHER
Principal Investigators
-
Gedske Daugaard · Rigshospitalet, Denmark
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-12-31
- Primary Completion
- 2012-02-29
- Completion
- 2012-02-29
Countries
- Denmark
Study Locations
More Related Trials
-
Use of Integrated PET/CT as a First Line Staging and Re-staging Technique in Oncologic Patient.
NCT06168877 ·Status: COMPLETED
-
Role of 18F-FDG PET/CT in Gastric Cancer
NCT05687552 ·Status: UNKNOWN
-
Positron Emission Tomography/Magnetic Resonance Imaging in Patients
NCT01557881 ·Status: TERMINATED ·Phase: NA
-
PET-CT in Diagnosis of Pancreatic Cystic Neoplasms
NCT01317836 ·Status: COMPLETED
-
PET and/or MRI Scans in Assessing Tumor Response in Patients Receiving Antiangiogenesis Therapy
NCT00019565 ·Status: COMPLETED ·Phase: PHASE1
-
PET/MR-imaging to Differentiate Between Responders and Non-responders Receiving Preoperative Chemotherapy
NCT02433301 ·Status: COMPLETED
-
Treatment Monitoring of Advanced Colorectal Cancer With 18F-FDG PET/CT
NCT00823810 ·Status: TERMINATED ·Phase: NA
-
Positron Emission Tomography (PET)/Computed Tomography (CT) and Roentgen in Lung Cancer: Evaluation of Patients in General Practice
NCT00675168 ·Status: UNKNOWN ·Phase: PHASE4
-
Functional Imaging of Tumor and Normal Tissue
NCT00933114 ·Status: TERMINATED
-
Diagnostic Comparison of PET-magnetic Resonance and PET-CT in Patients With Oncologic Diseases
NCT02316431 ·Status: COMPLETED
-
PET/CT-Assessment of Liver Tumor Ablation
NCT02018107 ·Status: COMPLETED ·Phase: NA
-
Role of Positron Emission Tomography in Detecting Primary Tumor in Cases of Metastases of Unknown Origin
NCT06086652 ·Status: RECRUITING
-
Role of PET/MRI in Head and Neck Cancer
NCT04360993 ·Status: COMPLETED
-
Relationship Between 18FDG PET/MRI Patterns and ctDNA to Predict HCC Recurrence After Liver Transplantation
NCT03839706 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Rectal Cancer: Local Staging, Re-staging and Assessment of Lymph Nodes Using Pet-Ct, CT-Perfusion and 3T MRI
NCT01525056 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of PET/MRI in Detecting Metastatic Disease in Endometrial Cancer
NCT02765698 ·Status: TERMINATED
-
A Comparison of FDG-PET Versus MRI Based Target Volume Delineation in Glioblastoma and the Role of FDG-PET/CT in the Alteration of MRI Based Target Volumes.
NCT01083719 ·Status: UNKNOWN ·Phase: PHASE2
-
Integrated PET/MR Imaging With Amino Acid Radiotracers in the Evaluation of Brain Neoplasms: Assessing Diagnostic Accuracy and Therapeutic Response
NCT07211360 ·Status: NOT_YET_RECRUITING
-
PRE- MISTIC: MRI and Cine Imaging to Improve Staging of Tumors in the Colon
NCT06216743 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
PET/MR in Surgical Planning for Breast CA Treated With Neoadj Chemo
NCT04149353 ·Status: TERMINATED ·Phase: NA
-
PET/MR in Assessing Response to Neoadjuvant Radiation Therapy in the Tx of High Grade Sarcomas
NCT03076333 ·Status: COMPLETED ·Phase: NA
-
[18F]F-FAPI PET-CT to Identify Carcinoma of Unknown Primary Origin
NCT06644716 ·Status: RECRUITING ·Phase: NA
-
Imaging Correlates of Renal Cell Carcinoma Biological Features
NCT01665703 ·Status: COMPLETED ·Phase: NA
-
Comparing the Diagnostic Role of PET/MRI and of PET/CT Among Patients With Gastric Cancer
NCT03015298 ·Status: UNKNOWN
-
[18F] PSMA-1007 PET/CT in Metastatic Clear Cell Renal Cell Carcinoma
NCT06428708 ·Status: RECRUITING ·Phase: EARLY_PHASE1